Trial Profile
Safety and Efficacy of Febuxostat in Advanced Ckd Patients with Hyperuricemia and did not meet with the target uric acid levels using allopurinol.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Hyperuricaemia
- Focus Adverse reactions; Therapeutic Use
- 06 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism